Skip to main content

Table 4 Estimated cases of cervical cancer, cervical cancer deaths, cervical intraepithelial neoplasia grade 1 (CIN 1), grade 2 (CIN 2), grade 3 (CIN 3) and genital warts cases per 100 000 women who are screened, or vaccinated and screened over a lifetime

From: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

  Cervical cancer cases Deaths from cervical cancer CIN 3 cases detected CIN 2 cases detected CIN 1 cases detected Genital warts cases
Screening only 715 218 5325 3906 12453 7147
Screening and vaccination 297 91 2846 2223 9899 2349
Case avoided 418 127 2479 1683 2554 4798
  1. * 85% vaccine coverage rate and lifetime duration of vaccine efficacy